Skip to content Skip to footer
Subscribe Now
Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science
VIEWPOINTS
Leonard Glass, Vice President, Global Medical Affairs at Eli Lilly & Co. Shares Insights from Lilly’s Vision on New Stage of Metabolic Science
Shots:Leonard spoke about how Lilly is advancing in the field of metabolic disease research (esp. diabetes)He also talked about its lead candidate in type 2 diabetes and also discussed its clinical results in detailThe interview summarizes Lilly’s objective to advance new discoveries and redefine diabetes careSmriti: Tell us how Lilly is leading…
August 16, 20220Comments
PharmaShots Interview Laurent Levy, CEO of Nanobiotix Shares Insights and Clinical Updates on its Nanoparticle Therapy
VIEWPOINTS
PharmaShots Interview: Laurent Levy, CEO of Nanobiotix Shares Insights and Clinical Updates on its Nanoparticle Therapy
Shots: Laurent spoke about the study design of its nanoparticle therapy to enhance the cancer-killing effect of radiation, which was presented at ASCO 2022Laurent also highlighted how this nanoparticle therapy can be a potential radio enhancer in various tumor types and across lines of therapyThe interview summarizes Nanobiotix’s vision to advance nanoparticles across…
August 10, 20220Comments
ThoughtSpot_Senior Editor
THOUGHTSPOT
The Emergence of Artificial Intelligence in the Pharmaceutical Industry
The dependability of digital technology has augmented through a variety of industries, including communication, transportation, manufacturing, medical, and pharmaceutical companies. Development in technologies has made it possible to merge medical science with digital platforms, allowing for the individualised delivery of services to a large population, making therapy more effective and convenient. Today, technology has become…
August 9, 20220Comments
Insights+ Key Biosimilars Events of July 2022
INSIGHTS+
Insights+ Key Biosimilars Events of July 2022
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potencyBiosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patientsDuring the month of July, Polpharma Biologics reported EMA's acceptance of MAA…
August 4, 20220Comments
PharmaShots Interview Dr. R. Preston Mason, Consultant at Amarin, Corp. Shares Insights from its in vitro Study Results
VIEWPOINTS
PharmaShots Interview: Dr. R. Preston Mason, Consultant at Amarin, Corp. Shares Insights from its in vitro Study Results
Shots:Dr. Mason spoke about the key findings from their in vitro study demonstrating EPA + statins effects in reduced lipid oxidation, which were presented at the ACC 2022He also spoke about the study design of the REDUCE-IT trial and its importance in the approval of its candidate in metabolic and cardiovascular diseasesThe interview summarizes…
August 3, 20220Comments
PharmaShots Interview Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Cancer
VIEWPOINTS
PharmaShots Interview: Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Cancer
Shots: Purnanand spoke about the preclinical results of lead candidate in oncology and how its identifies IL-38 as a target to treat cancerPurnanand also talked about Immunome’s collaboration with Fox Chase Cancer Center for the further development of its prime productThe interview gives a understanding of Immunome’s goal of developing therapeutics to treat…
August 2, 20220Comments
Exclusive Interview_Philip M. Brown_Dr. Anna Tallman
EXCLUSIVE
Philip Brown & Anna Tallman of Dermavant Shares Insights on the Approval of its Topical Treatment for Plaque Psoriasis
Shots:Philip spoke about plaque psoriasis, symptoms, prognosis, and treatment options available. He also discussed different ongoing patient support programs by DermavantAnna talked about the approval of Dermavant’s lead topical treatment in plaque psoriasis, its clinical studies & resultsThe interview summarizes Dermavant’s aim to develop innovative therapeutics in immuno-dermatology to address the high…
August 1, 20220Comments